Gene · 2046
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. | Cancer Res | 2023 | 36318118 | PubTator, text mining | PubMed |
Thiadiazole Functionalized Salicylaldehyde-Schiff Base as a pH-responsive and chemo-reversible "Turn-Off" fluorescent probe for selective cu (II) detection: Logic Gate Behaviour and Molecular Docking Studies. | J Fluoresc | 2023 | 36208370 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals the adverse effects of cadmium on the trajectory of neuronal maturation. | Cell Biol Toxicol | 2023 | 36114956 | PubTator, text mining | PubMed |
| EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma. | Cancer Med | 2023 | 35770949 | PubTator, text mining | PubMed |
| Endothelin-1 Induced Phosphorylation of Caveolin-1 and Smad2C in Human Vascular Smooth Muscle Cells: Role of NADPH Oxidases, c-Abl, and Caveolae Integrity in TGF-β Receptor Transactivation. | Int J Mol Cell Med | 2022 | 37727643 | PubTator, text mining | PubMed |
| Improving Radiotherapy Response in the Treatment of Head and Neck Cancer. | Crit Rev Oncog | 2022 | 36734873 | PubTator, text mining | PubMed |
| Study on the molecular mechanism of anti-liver cancer effect of Evodiae fructus by network pharmacology and QSAR model. | Front Chem | 2022 | 36700075 | PubTator, text mining | PubMed |
| Pathways Activated by Infected and Bystander Chondrocytes in Response to Ross River Virus Infection. | Viruses | 2022 | 36680176 | PubTator, text mining | PubMed |
| Tyrosine kinases in KMT2A/MLL-rearranged acute leukemias as potential therapeutic targets to overcome cancer drug resistance. | Cancer Drug Resist | 2022 | 36627892 | PubTator, text mining | PubMed |
| Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. | Cancers (Basel) | 2022 | 36612019 | PubTator, text mining | PubMed |
| Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer. | Front Mol Neurosci | 2022 | 36590916 | PubTator, text mining | PubMed |
| Biomarker-driven drug repurposing on biologically similar cancers with DNA-repair deficiencies. | Front Genet | 2022 | 36583025 | PubTator, text mining | PubMed |
| TAPE-seq is a cell-based method for predicting genome-wide off-target effects of prime editor. | Nat Commun | 2022 | 36581624 | PubTator, text mining | PubMed |
| EphA3 targeted by miR-3666 contributes to melanoma malignancy via activating ERK1/2 and p38 MAPK pathways. | Open Med (Wars) | 2022 | 36578556 | PubTator, text mining | PubMed |
| Intraductal oncocytic papillary neoplasm arising in Peutz-Jeghers Syndrome bile duct: a unique case report. | Diagn Pathol | 2022 | 36578081 | PubTator, text mining | PubMed |
| Bioinformatics analysis identifies immune-related gene signatures and subtypes in diabetic nephropathy. | Front Endocrinol (Lausanne) | 2022 | 36568106 | PubTator, text mining | PubMed |
| Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases. | Viruses | 2022 | 36560690 | PubTator, text mining | PubMed |
| Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy. | Pharmaceutics | 2022 | 36559200 | PubTator, text mining | PubMed |
| COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction. | Front Oncol | 2022 | 36530986 | PubTator, text mining | PubMed |
| CryoEM structures of anion exchanger 1 capture multiple states of inward- and outward-facing conformations. | Commun Biol | 2022 | 36517642 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2046/papers?page=11